385 related articles for article (PubMed ID: 35207632)
1. Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics.
Han MN; Finkelstein DI; McQuade RM; Diwakarla S
J Pers Med; 2022 Jan; 12(2):. PubMed ID: 35207632
[TBL] [Abstract][Full Text] [Related]
2. The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease.
Barboza JL; Okun MS; Moshiree B
Expert Opin Pharmacother; 2015; 16(16):2449-64. PubMed ID: 26374094
[TBL] [Abstract][Full Text] [Related]
3. A Critical Analysis of Intestinal Enteric Neuron Loss and Constipation in Parkinson's Disease.
O'Day C; Finkelstein DI; Diwakarla S; McQuade RM
J Parkinsons Dis; 2022; 12(6):1841-1861. PubMed ID: 35848035
[TBL] [Abstract][Full Text] [Related]
4. The Gut and Nonmotor Symptoms in Parkinson's Disease.
Klingelhoefer L; Reichmann H
Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal dysmotility in rodent models of Parkinson's disease.
Pellegrini C; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2024 Apr; 326(4):G345-G359. PubMed ID: 38261717
[TBL] [Abstract][Full Text] [Related]
6. Enteric nervous system manifestations of neurodegenerative disease.
Chalazonitis A; Rao M
Brain Res; 2018 Aug; 1693(Pt B):207-213. PubMed ID: 29360466
[TBL] [Abstract][Full Text] [Related]
7. MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson's disease.
Ghaisas S; Langley MR; Palanisamy BN; Dutta S; Narayanaswamy K; Plummer PJ; Sarkar S; Ay M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2019 Dec; 75():186-199. PubMed ID: 31505196
[TBL] [Abstract][Full Text] [Related]
8. Management of dysphagia and gastroparesis in Parkinson's disease in real-world clinical practice - Balancing pharmacological and non-pharmacological approaches.
Bhidayasiri R; Phuenpathom W; Tan AH; Leta V; Phumphid S; Chaudhuri KR; Pal PK
Front Aging Neurosci; 2022; 14():979826. PubMed ID: 36034128
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility.
Yan Y; Shimoga D; Sharma A
Curr Gastroenterol Rep; 2023 May; 25(5):106-113. PubMed ID: 37067721
[TBL] [Abstract][Full Text] [Related]
10. Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence.
Pellegrini C; Antonioli L; Colucci R; Ballabeni V; Barocelli E; Bernardini N; Blandizzi C; Fornai M
Parkinsonism Relat Disord; 2015 Dec; 21(12):1407-14. PubMed ID: 26499757
[TBL] [Abstract][Full Text] [Related]
11. Gut dysfunction in Parkinson's disease.
Mukherjee A; Biswas A; Das SK
World J Gastroenterol; 2016 Jul; 22(25):5742-52. PubMed ID: 27433087
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal Dysfunction in Parkinson's Disease.
Safarpour D; Sharzehi K; Pfeiffer RF
Drugs; 2022 Feb; 82(2):169-197. PubMed ID: 35076890
[TBL] [Abstract][Full Text] [Related]
13. Beyond the Microbiota: Understanding the Role of the Enteric Nervous System in Parkinson's Disease from Mice to Human.
Montanari M; Imbriani P; Bonsi P; Martella G; Peppe A
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371655
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal dysfunction in Parkinson's disease.
Lubomski M; Davis RL; Sue CM
J Neurol; 2020 May; 267(5):1377-1388. PubMed ID: 31989280
[TBL] [Abstract][Full Text] [Related]
15. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects.
Ramprasad C; Douglas JY; Moshiree B
Curr Treat Options Gastroenterol; 2018 Dec; 16(4):489-510. PubMed ID: 30361854
[TBL] [Abstract][Full Text] [Related]
17. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson's disease.
Johnson ME; Stringer A; Bobrovskaya L
Neurotoxicology; 2018 Mar; 65():174-185. PubMed ID: 29471018
[TBL] [Abstract][Full Text] [Related]
18. Relation of Enteric α-Synuclein to Gastrointestinal Dysfunction in Patients With Parkinson's Disease and in Neurologically Intact Subjects.
Lee HJ; Jung KW; Chung SJ; Hong SM; Kim J; Lee JH; Hwang SW; Ryu HS; Kim MJ; Lee HS; Seo M; Park SH; Yang DH; Ye BD; Byeon JS; Choe J; Jung HY; Yang SK; Myung SJ
J Neurogastroenterol Motil; 2018 Jul; 24(3):469-478. PubMed ID: 29969861
[TBL] [Abstract][Full Text] [Related]
19. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies.
Perez-Pardo P; Kliest T; Dodiya HB; Broersen LM; Garssen J; Keshavarzian A; Kraneveld AD
Eur J Pharmacol; 2017 Dec; 817():86-95. PubMed ID: 28549787
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal Dysfunction in Parkinson's Disease.
Pfeiffer RF
Curr Treat Options Neurol; 2018 Oct; 20(12):54. PubMed ID: 30361783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
